Renaissance Technologies LLC Has $902,000 Stock Holdings in Rockwell Medical, Inc. (NASDAQ:RMTI)

featured-image

Renaissance Technologies LLC grew its stake in Rockwell Medical, Inc. (NASDAQ:RMTI – Free Report) by 285.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 442,350 shares of the company’s stock after buying an additional 327,678 shares during the period. Renaissance Technologies [...]

Renaissance Technologies LLC grew its stake in Rockwell Medical, Inc. (NASDAQ:RMTI – Free Report) by 285.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.

The firm owned 442,350 shares of the company’s stock after buying an additional 327,678 shares during the period. Renaissance Technologies LLC owned 1.37% of Rockwell Medical worth $902,000 as of its most recent filing with the Securities and Exchange Commission.



Several other large investors have also added to or reduced their stakes in RMTI. Jane Street Group LLC acquired a new stake in Rockwell Medical during the third quarter worth approximately $534,000. JPMorgan Chase & Co.

grew its stake in Rockwell Medical by 134,397.1% during the third quarter. JPMorgan Chase & Co.

now owns 47,074 shares of the company’s stock worth $187,000 after purchasing an additional 47,039 shares during the period. LPL Financial LLC grew its stake in Rockwell Medical by 91.3% during the fourth quarter.

LPL Financial LLC now owns 54,872 shares of the company’s stock worth $112,000 after purchasing an additional 26,191 shares during the period. Barclays PLC acquired a new stake in Rockwell Medical during the third quarter worth approximately $90,000. Finally, State Street Corp grew its stake in Rockwell Medical by 21.

5% during the third quarter. State Street Corp now owns 95,004 shares of the company’s stock worth $377,000 after purchasing an additional 16,800 shares during the period. Institutional investors and hedge funds own 23.

31% of the company’s stock. Insider Buying and Selling at Rockwell MedicalIn other news, major shareholder Larson Family Inve Irrevocable acquired 57,000 shares of Rockwell Medical stock in a transaction on Thursday, April 10th. The stock was purchased at an average price of $1.

07 per share, with a total value of $60,990.00. Following the completion of the purchase, the insider now owns 3,527,000 shares of the company’s stock, valued at approximately $3,773,890.

The trade was a 1.64 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Over the last quarter, insiders sold 10,680 shares of company stock valued at $11,552. Company insiders own 1.90% of the company’s stock.

Rockwell Medical Trading Down 1.8 %Shares of Rockwell Medical stock opened at $1.08 on Thursday.

The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.

41. Rockwell Medical, Inc. has a 52 week low of $0.

86 and a 52 week high of $5.15. The stock has a 50 day moving average price of $1.

31 and a two-hundred day moving average price of $2.08. The stock has a market capitalization of $36.

91 million, a PE ratio of -21.60 and a beta of 1.62.

Rockwell Medical (NASDAQ:RMTI – Get Free Report) last announced its quarterly earnings data on Thursday, March 20th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of $0.

02 by ($0.04). Rockwell Medical had a negative net margin of 1.

25% and a positive return on equity of 8.55%. The firm had revenue of $24.

67 million during the quarter, compared to analyst estimates of $23.65 million. As a group, equities analysts anticipate that Rockwell Medical, Inc.

will post 0.03 earnings per share for the current fiscal year. Wall Street Analyst Weigh InSeparately, HC Wainwright decreased their target price on Rockwell Medical from $7.

00 to $3.00 and set a “buy” rating for the company in a research note on Monday, March 24th.View Our Latest Stock Analysis on Rockwell MedicalRockwell Medical Company Profile (Free Report)Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide.

The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.See AlsoFive stocks we like better than Rockwell MedicalUptrend Stocks Explained: Learn How to Trade Using UptrendsWhy D-Wave’s Project With Davidson Is a Game-Changer For QuantumWhat is a Dividend Harvesting Strategy and How Can Investors Profit from it?Hims & Hers Stock Soars on Novo Nordisk CollaborationWhat Are Dividend Champions? How to Invest in the ChampionsAmazon’s Earnings Will Make or Break the Stock’s Comeback Want to see what other hedge funds are holding RMTI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rockwell Medical, Inc.

(NASDAQ:RMTI – Free Report)..